PARP-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of PARP-1 monoclonal antibodies for research focused on Poly(ADP-ribose) polymerase 1 (PARP-1) in cellular processes. PARP-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PARP-1 functions as a key enzyme in cellular responses to DNA damage, with essential roles in DNA repair, genomic stability, and programmed cell death. Understanding PARP-1 activity provides insights into cellular homeostasis maintenance and reveals important connections to cancer biology, neurodegenerative diseases, and aging processes. Research on PARP-1 continues to advance the development of targeted therapies, particularly in oncology where PARP inhibitors show significant therapeutic potential. Scientists worldwide rely on PARP-1 monoclonal antibodies to uncover new pathways and mechanisms in DNA repair and cell death. Ongoing studies of PARP-1 reveal its expanding roles in cellular regulation and disease progression. PARP-1 research supported by Santa Cruz Biotechnology monoclonal antibodies contributes to breakthrough discoveries that advance therapeutic strategies and scientific understanding.